BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2078 related articles for article (PubMed ID: 33739374)

  • 1. Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination.
    Edara VV; Hudson WH; Xie X; Ahmed R; Suthar MS
    JAMA; 2021 May; 325(18):1896-1898. PubMed ID: 33739374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.
    Edara VV; Pinsky BA; Suthar MS; Lai L; Davis-Gardner ME; Floyd K; Flowers MW; Wrammert J; Hussaini L; Ciric CR; Bechnak S; Stephens K; Graham BS; Bayat Mokhtari E; Mudvari P; Boritz E; Creanga A; Pegu A; Derrien-Colemyn A; Henry AR; Gagne M; Douek DC; Sahoo MK; Sibai M; Solis D; Webby RJ; Jeevan T; Fabrizio TP
    N Engl J Med; 2021 Aug; 385(7):664-666. PubMed ID: 34233096
    [No Abstract]   [Full Text] [Related]  

  • 3. BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants.
    Liu Y; Liu J; Xia H; Zhang X; Zou J; Fontes-Garfias CR; Weaver SC; Swanson KA; Cai H; Sarkar R; Chen W; Cutler M; Cooper D; Muik A; Sahin U; Jansen KU; Xie X; Dormitzer PR; Shi PY
    N Engl J Med; 2021 Jul; 385(5):472-474. PubMed ID: 33979486
    [No Abstract]   [Full Text] [Related]  

  • 4. Study Suggests Lasting Immunity After COVID-19, With a Big Boost From Vaccination.
    Abbasi J
    JAMA; 2021 Aug; 326(5):376-377. PubMed ID: 34259836
    [No Abstract]   [Full Text] [Related]  

  • 5. SARS-CoV-2 Antibody Response in Persons with Past Natural Infection.
    Anichini G; Terrosi C; Gandolfo C; Gori Savellini G; Fabrizi S; Miceli GB; Cusi MG
    N Engl J Med; 2021 Jul; 385(1):90-92. PubMed ID: 33852796
    [No Abstract]   [Full Text] [Related]  

  • 6. SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons.
    Rössler A; Riepler L; Bante D; von Laer D; Kimpel J
    N Engl J Med; 2022 Feb; 386(7):698-700. PubMed ID: 35021005
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough Infection.
    Bates TA; McBride SK; Winders B; Schoen D; Trautmann L; Curlin ME; Tafesse FG
    JAMA; 2022 Jan; 327(2):179-181. PubMed ID: 34914825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Neutralization of the SARS-CoV-2 Omicron Variant.
    Schmidt F; Muecksch F; Weisblum Y; Da Silva J; Bednarski E; Cho A; Wang Z; Gaebler C; Caskey M; Nussenzweig MC; Hatziioannou T; Bieniasz PD
    N Engl J Med; 2022 Feb; 386(6):599-601. PubMed ID: 35030645
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine.
    Bradley T; Grundberg E; Selvarangan R; LeMaster C; Fraley E; Banerjee D; Belden B; Louiselle D; Nolte N; Biswell R; Pastinen T; Myers A; Schuster J
    N Engl J Med; 2021 May; 384(20):1959-1961. PubMed ID: 33755375
    [No Abstract]   [Full Text] [Related]  

  • 10. SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans.
    Forgacs D; Jang H; Abreu RB; Hanley HB; Gattiker JL; Jefferson AM; Ross TM
    Front Immunol; 2021; 12():728021. PubMed ID: 34646267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.
    Normark J; Vikström L; Gwon YD; Persson IL; Edin A; Björsell T; Dernstedt A; Christ W; Tevell S; Evander M; Klingström J; Ahlm C; Forsell M
    N Engl J Med; 2021 Sep; 385(11):1049-1051. PubMed ID: 34260850
    [No Abstract]   [Full Text] [Related]  

  • 12. SARS-CoV-2 Variant Antibodies Wane 6 Months After Vaccination.
    Abbasi J
    JAMA; 2021 Sep; 326(10):901. PubMed ID: 34519816
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of neutralizing antibody responses against SARS-CoV-2 in healthy volunteers who received the BNT162b2 mRNA or the AZD1222 vaccine: Should the second AZD1222 vaccine dose be given earlier?
    Terpos E; Trougakos IP; Karalis V; Ntanasis-Stathopoulos I; Sklirou AD; Bagratuni T; Papanagnou ED; Patseas D; Gumeni S; Malandrakis P; Korompoki E; Dimopoulos MA
    Am J Hematol; 2021 Sep; 96(9):E321-E324. PubMed ID: 34028867
    [No Abstract]   [Full Text] [Related]  

  • 14. Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2.
    Lustig Y; Nemet I; Kliker L; Zuckerman N; Yishai R; Alroy-Preis S; Mendelson E; Mandelboim M
    N Engl J Med; 2021 Jun; 384(25):2453-2454. PubMed ID: 33826815
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of a Prolonged Booster Interval on Neutralization of Omicron Variant.
    Zhao X; Li D; Ruan W; Chen Z; Zhang R; Zheng A; Qiao S; Zheng X; Zhao Y; Dai L; Han P; Gao GF
    N Engl J Med; 2022 Mar; 386(9):894-896. PubMed ID: 35081296
    [No Abstract]   [Full Text] [Related]  

  • 16. The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity.
    Abbasi J
    JAMA; 2021 Nov; 326(18):1781-1782. PubMed ID: 34673883
    [No Abstract]   [Full Text] [Related]  

  • 17. Audio Interview: How Well Are Covid-19 Vaccines Working?
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Jul; 385(2):e15. PubMed ID: 34233102
    [No Abstract]   [Full Text] [Related]  

  • 18. Can immune responses predict which vaccines work best?
    Cohen J
    Science; 2021 Jul; 373(6551):142-143. PubMed ID: 34244387
    [No Abstract]   [Full Text] [Related]  

  • 19. SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3.
    Falsey AR; Frenck RW; Walsh EE; Kitchin N; Absalon J; Gurtman A; Lockhart S; Bailey R; Swanson KA; Xu X; Koury K; Kalina W; Cooper D; Zou J; Xie X; Xia H; Türeci Ö; Lagkadinou E; Tompkins KR; Shi PY; Jansen KU; Şahin U; Dormitzer PR; Gruber WC
    N Engl J Med; 2021 Oct; 385(17):1627-1629. PubMed ID: 34525276
    [No Abstract]   [Full Text] [Related]  

  • 20. Previous Infection Combined with Vaccination Produces Neutralizing Antibodies with Potency against SARS-CoV-2 Variants.
    Ibarrondo FJ; Hofmann C; Ali A; Ayoub P; Kohn DB; Yang OO
    mBio; 2021 Dec; 12(6):e0265621. PubMed ID: 34872349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 104.